| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.093 | 0.08 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.19 | 0.08 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |